Jump Financial’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,676
| Closed | -$229K | – | 1866 |
|
|
2024
Q4 | $229K | Sell |
1,676
-39,078
| -96% | -$5.33M | ﹤0.01% | 1432 |
|
|
2024
Q3 | $4.7M | Buy |
+40,754
| New | +$4.7M | 0.1% | 242 |
|
|
2024
Q1 | – | Sell |
-16,905
| Closed | -$2.23M | – | 2149 |
|
|
2023
Q4 | $2.23M | Buy |
16,905
+9,023
| +114% | +$1.19M | 0.07% | 339 |
|
|
2023
Q3 | $887K | Buy |
+7,882
| New | +$887K | 0.03% | 725 |
|
|
2023
Q2 | – | Sell |
-10,200
| Closed | -$1.03M | – | 2035 |
|
|
2023
Q1 | $1.03M | Sell |
10,200
-36,122
| -78% | -$3.66M | 0.04% | 586 |
|
|
2022
Q4 | $5.53M | Sell |
46,322
-10,878
| -19% | -$1.3M | 0.29% | 78 |
|
|
2022
Q3 | $6.08M | Buy |
+57,200
| New | +$6.08M | 0.24% | 114 |
|
|
2020
Q4 | – | Sell |
-4,725
| Closed | -$455K | – | 1101 |
|
|
2020
Q3 | $455K | Buy |
+4,725
| New | +$455K | 0.09% | 356 |
|